|
Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD
RECRUITINGSponsored by University of Southern California
Actively Recruiting
SponsorUniversity of Southern California
Started2025-09-29
Est. completion2027-09-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT07186699
Summary
This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts care for non-small cell lung cancer.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * \* Adults ≥ 18 years of age * Histopathologic or cytologic diagnosis of NSCLC * Received or receiving curative intent treatment (e.g. surgery, radiation therapy, systemic therapy) * History of alcohol use or substance use disorder (other than tobacco use disorder) within the past 10 years, predating the cancer diagnosis * Ability to understand and the willingness to sign a written informed consent * English or Spanish speaking. Due to need to conduct semi-structured interviews which can develop into free-flowing conversations we need both participant and interviewer to be fluent Exclusion Criteria: * Patients with cognitive disability unable to maintain 30-60 minute conversation
Conditions3
CancerLung CancerLung Non-Small Cell Carcinoma
Locations2 sites
Los Angeles General Medical Center
Los Angeles, California, 90033
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorUniversity of Southern California
Started2025-09-29
Est. completion2027-09-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT07186699